1. Home
  2. BV vs PCRX Comparison

BV vs PCRX Comparison

Compare BV & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrightView Holdings Inc.

BV

BrightView Holdings Inc.

N/A

Current Price

$12.14

Market Cap

1.0B

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$36.40

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BV
PCRX
Founded
1939
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
BV
PCRX
Price
$12.14
$36.40
Analyst Decision
Buy
Hold
Analyst Count
11
9
Target Price
$15.35
★ $33.57
AVG Volume (30 Days)
813.3K
★ 2.3M
Earning Date
11-10-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 107.44
EPS
N/A
★ 0.19
Revenue
N/A
★ $541,533,000.00
Revenue This Year
$3.21
$3.84
Revenue Next Year
$0.18
$4.73
P/E Ratio
★ N/A
$191.58
Revenue Growth
N/A
★ 26.04
52 Week Low
$9.82
$18.80
52 Week High
$15.00
$36.67

Technical Indicators

Market Signals
Indicator
BV
PCRX
Relative Strength Index (RSI) 75.26 83.12
Support Level $11.47 $21.97
Resistance Level $12.59 $36.45
Average True Range (ATR) 0.33 0.09
MACD 0.19 -0.28
Stochastic Oscillator 92.68 25.35

Price Performance

Historical Comparison
BV
PCRX

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: